ヘパリン有効成分世界市場の発展状況と動向 2024-2030

QY Research > レポート一覧 > 薬品及びサプリメント > ヘパリン有効成分世界市場の発展状況と動向 2024-2030

英文タイトル： Global Heparin Active Pharmaceutical Ingredients Market Insights, Forecast to 2030

レポートID：105424
発表時期：2024-04-25
訪問回数：575
ページ数：116
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：143
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=148.40円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=148.40円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、ヘパリン有効成分の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にヘパリン有効成分市場を分類しています。

本レポートでは世界のヘパリン有効成分市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Shenzhen Hepalink Pharmaceutical、Yantai Dongcheng Pharmaceutical、Nanjing King-friend Biochemical Pharmaceutical、Pfizer、Hebei Changshan Biochemical Pharmaceutical、Bioibérica、Qingdao Jiulong Biopharmaceutical、Changzhou Qianhong Biopharma、Dongying Tiandong Pharmaceutical、Opocrin、Hubei Enoray Biopharmaceutical、Yino Pharma、Cisen Pharmaceutical、Nanjing Xinbai Pharmaceutical、Sichuan Deebio Pharmaceutical

レポートはヘパリン有効成分の主要生産者を調査し、主要地域や国の消費状況も提供します。ヘパリン有効成分の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント：
Heparin Sodium
Heparin Calcium

用途別の市場セグメント：
UFH
LMWH

本レポートの詳細内容
本レポートは、世界のヘパリン有効成分市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてヘパリン有効成分市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）のヘパリン有効成分生産量、成長率、市場シェアを調査している。

二. 消費面では、ヘパリン有効成分の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのヘパリン有効成分売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のヘパリン有効成分市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ヘパリン有効成分のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

第1章：ヘパリン有効成分のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章：ヘパリン有効成分の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおけるヘパリン有効成分の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章ヘパリン有効成分メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：ヘパリン有効成分の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：ヘパリン有効成分の主要メーカーの概要を提供し、製品の説明と仕様、ヘパリン有効成分の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ヘパリン有効成分の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

概要

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.
Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

The global Heparin Active Pharmaceutical Ingredients market is projected to grow from US$ 3017.2 million in 2024 to US$ 6116.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.

In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply.
Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%.
The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue.
Report Covers:
This report presents an overview of global market for Heparin Active Pharmaceutical Ingredients, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Heparin Active Pharmaceutical Ingredients, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Heparin Active Pharmaceutical Ingredients, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Heparin Active Pharmaceutical Ingredients sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Heparin Active Pharmaceutical Ingredients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Heparin Active Pharmaceutical Ingredients sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma and Dongying Tiandong Pharmaceutical, etc.

Market Segmentation
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical

Segment by Type
Heparin Sodium
Heparin Calcium

Segment by Application
UFH
LMWH

Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Heparin Active Pharmaceutical Ingredients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Heparin Active Pharmaceutical Ingredients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heparin Active Pharmaceutical Ingredients sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

総目録

1 Study Coverage
1.1 Heparin Active Pharmaceutical Ingredients Product Introduction
1.2 Market by Type
1.2.1 Global Heparin Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Market by Application
1.3.1 Global Heparin Active Pharmaceutical Ingredients Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 UFH
1.3.3 LMWH
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Heparin Active Pharmaceutical Ingredients Sales Estimates and Forecasts 2019-2030
2.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Region
2.2.1 Global Heparin Active Pharmaceutical Ingredients Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Region (2019-2024)
2.2.3 Global Heparin Active Pharmaceutical Ingredients Revenue by Region (2025-2030)
2.2.4 Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Region (2019-2030)
2.3 Global Heparin Active Pharmaceutical Ingredients Sales Estimates and Forecasts 2019-2030
2.4 Global Heparin Active Pharmaceutical Ingredients Sales by Region
2.4.1 Global Heparin Active Pharmaceutical Ingredients Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Heparin Active Pharmaceutical Ingredients Sales by Region (2019-2024)
2.4.3 Global Heparin Active Pharmaceutical Ingredients Sales by Region (2025-2030)
2.4.4 Global Heparin Active Pharmaceutical Ingredients Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufactures
3.1 Global Heparin Active Pharmaceutical Ingredients Sales by Manufacturers
3.1.1 Global Heparin Active Pharmaceutical Ingredients Sales by Manufacturers (2019-2024)
3.1.2 Global Heparin Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Heparin Active Pharmaceutical Ingredients in 2023
3.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Manufacturers
3.2.1 Global Heparin Active Pharmaceutical Ingredients Revenue by Manufacturers (2019-2024)
3.2.2 Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Heparin Active Pharmaceutical Ingredients Revenue in 2023
3.3 Global Key Players of Heparin Active Pharmaceutical Ingredients, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Heparin Active Pharmaceutical Ingredients Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Heparin Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Heparin Active Pharmaceutical Ingredients, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Heparin Active Pharmaceutical Ingredients, Product Offered and Application
3.8 Global Key Manufacturers of Heparin Active Pharmaceutical Ingredients, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Heparin Active Pharmaceutical Ingredients Sales by Type
4.1.1 Global Heparin Active Pharmaceutical Ingredients Historical Sales by Type (2019-2024)
4.1.2 Global Heparin Active Pharmaceutical Ingredients Forecasted Sales by Type (2025-2030)
4.1.3 Global Heparin Active Pharmaceutical Ingredients Sales Market Share by Type (2019-2030)
4.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Type
4.2.1 Global Heparin Active Pharmaceutical Ingredients Historical Revenue by Type (2019-2024)
4.2.2 Global Heparin Active Pharmaceutical Ingredients Forecasted Revenue by Type (2025-2030)
4.2.3 Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Type (2019-2030)
4.3 Global Heparin Active Pharmaceutical Ingredients Price by Type
4.3.1 Global Heparin Active Pharmaceutical Ingredients Price by Type (2019-2024)
4.3.2 Global Heparin Active Pharmaceutical Ingredients Price Forecast by Type (2025-2030)

5 Market Size by Application
5.1 Global Heparin Active Pharmaceutical Ingredients Sales by Application
5.1.1 Global Heparin Active Pharmaceutical Ingredients Historical Sales by Application (2019-2024)
5.1.2 Global Heparin Active Pharmaceutical Ingredients Forecasted Sales by Application (2025-2030)
5.1.3 Global Heparin Active Pharmaceutical Ingredients Sales Market Share by Application (2019-2030)
5.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Application
5.2.1 Global Heparin Active Pharmaceutical Ingredients Historical Revenue by Application (2019-2024)
5.2.2 Global Heparin Active Pharmaceutical Ingredients Forecasted Revenue by Application (2025-2030)
5.2.3 Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Application (2019-2030)
5.3 Global Heparin Active Pharmaceutical Ingredients Price by Application
5.3.1 Global Heparin Active Pharmaceutical Ingredients Price by Application (2019-2024)
5.3.2 Global Heparin Active Pharmaceutical Ingredients Price Forecast by Application (2025-2030)

6 US & Canada
6.1 US & Canada Heparin Active Pharmaceutical Ingredients Market Size by Type
6.1.1 US & Canada Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2030)
6.1.2 US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2030)
6.2 US & Canada Heparin Active Pharmaceutical Ingredients Market Size by Application
6.2.1 US & Canada Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2030)
6.2.2 US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2030)
6.3 US & Canada Heparin Active Pharmaceutical Ingredients Market Size by Country
6.3.1 US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Heparin Active Pharmaceutical Ingredients Sales by Country (2019-2030)
6.3.3 US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Heparin Active Pharmaceutical Ingredients Market Size by Type
7.1.1 Europe Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2030)
7.1.2 Europe Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2030)
7.2 Europe Heparin Active Pharmaceutical Ingredients Market Size by Application
7.2.1 Europe Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2030)
7.2.2 Europe Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2030)
7.3 Europe Heparin Active Pharmaceutical Ingredients Market Size by Country
7.3.1 Europe Heparin Active Pharmaceutical Ingredients Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Heparin Active Pharmaceutical Ingredients Sales by Country (2019-2030)
7.3.3 Europe Heparin Active Pharmaceutical Ingredients Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Heparin Active Pharmaceutical Ingredients Market Size
8.1.1 China Heparin Active Pharmaceutical Ingredients Sales (2019-2030)
8.1.2 China Heparin Active Pharmaceutical Ingredients Revenue (2019-2030)
8.2 China Heparin Active Pharmaceutical Ingredients Market Size by Application
8.2.1 China Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2030)
8.2.2 China Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Heparin Active Pharmaceutical Ingredients Market Size by Type
9.1.1 Asia Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2030)
9.1.2 Asia Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2030)
9.2 Asia Heparin Active Pharmaceutical Ingredients Market Size by Application
9.2.1 Asia Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2030)
9.2.2 Asia Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2030)
9.3 Asia Heparin Active Pharmaceutical Ingredients Sales by Region
9.3.1 Asia Heparin Active Pharmaceutical Ingredients Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Heparin Active Pharmaceutical Ingredients Revenue by Region (2019-2030)
9.3.3 Asia Heparin Active Pharmaceutical Ingredients Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Market Size by Type
10.1.1 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Market Size by Application
10.2.1 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Country
10.3.1 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Company Profiles
11.1 Shenzhen Hepalink Pharmaceutical
11.1.1 Shenzhen Hepalink Pharmaceutical Company Information
11.1.2 Shenzhen Hepalink Pharmaceutical Overview
11.1.3 Shenzhen Hepalink Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Shenzhen Hepalink Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments
11.2 Yantai Dongcheng Pharmaceutical
11.2.1 Yantai Dongcheng Pharmaceutical Company Information
11.2.2 Yantai Dongcheng Pharmaceutical Overview
11.2.3 Yantai Dongcheng Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Yantai Dongcheng Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Yantai Dongcheng Pharmaceutical Recent Developments
11.3 Nanjing King-friend Biochemical Pharmaceutical
11.3.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
11.3.2 Nanjing King-friend Biochemical Pharmaceutical Overview
11.3.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Pfizer Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Hebei Changshan Biochemical Pharmaceutical
11.5.1 Hebei Changshan Biochemical Pharmaceutical Company Information
11.5.2 Hebei Changshan Biochemical Pharmaceutical Overview
11.5.3 Hebei Changshan Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Hebei Changshan Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
11.6 Bioibérica
11.6.1 Bioibérica Company Information
11.6.2 Bioibérica Overview
11.6.3 Bioibérica Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Bioibérica Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bioibérica Recent Developments
11.7 Qingdao Jiulong Biopharmaceutical
11.7.1 Qingdao Jiulong Biopharmaceutical Company Information
11.7.2 Qingdao Jiulong Biopharmaceutical Overview
11.7.3 Qingdao Jiulong Biopharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Qingdao Jiulong Biopharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Qingdao Jiulong Biopharmaceutical Recent Developments
11.8 Changzhou Qianhong Biopharma
11.8.1 Changzhou Qianhong Biopharma Company Information
11.8.2 Changzhou Qianhong Biopharma Overview
11.8.3 Changzhou Qianhong Biopharma Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Changzhou Qianhong Biopharma Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Changzhou Qianhong Biopharma Recent Developments
11.9 Dongying Tiandong Pharmaceutical
11.9.1 Dongying Tiandong Pharmaceutical Company Information
11.9.2 Dongying Tiandong Pharmaceutical Overview
11.9.3 Dongying Tiandong Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Dongying Tiandong Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dongying Tiandong Pharmaceutical Recent Developments
11.10 Opocrin
11.10.1 Opocrin Company Information
11.10.2 Opocrin Overview
11.10.3 Opocrin Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Opocrin Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Opocrin Recent Developments
11.11 Hubei Enoray Biopharmaceutical
11.11.1 Hubei Enoray Biopharmaceutical Company Information
11.11.2 Hubei Enoray Biopharmaceutical Overview
11.11.3 Hubei Enoray Biopharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hubei Enoray Biopharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hubei Enoray Biopharmaceutical Recent Developments
11.12 Yino Pharma
11.12.1 Yino Pharma Company Information
11.12.2 Yino Pharma Overview
11.12.3 Yino Pharma Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Yino Pharma Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Yino Pharma Recent Developments
11.13 Cisen Pharmaceutical
11.13.1 Cisen Pharmaceutical Company Information
11.13.2 Cisen Pharmaceutical Overview
11.13.3 Cisen Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Cisen Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Cisen Pharmaceutical Recent Developments
11.14 Nanjing Xinbai Pharmaceutical
11.14.1 Nanjing Xinbai Pharmaceutical Company Information
11.14.2 Nanjing Xinbai Pharmaceutical Overview
11.14.3 Nanjing Xinbai Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Nanjing Xinbai Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Nanjing Xinbai Pharmaceutical Recent Developments
11.15 Sichuan Deebio Pharmaceutical
11.15.1 Sichuan Deebio Pharmaceutical Company Information
11.15.2 Sichuan Deebio Pharmaceutical Overview
11.15.3 Sichuan Deebio Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Sichuan Deebio Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sichuan Deebio Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Heparin Active Pharmaceutical Ingredients Industry Chain Analysis
12.2 Heparin Active Pharmaceutical Ingredients Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Heparin Active Pharmaceutical Ingredients Production Mode & Process
12.4 Heparin Active Pharmaceutical Ingredients Sales and Marketing
12.4.1 Heparin Active Pharmaceutical Ingredients Sales Channels
12.4.2 Heparin Active Pharmaceutical Ingredients Distributors
12.5 Heparin Active Pharmaceutical Ingredients Customers

13 Market Dynamics
13.1 Heparin Active Pharmaceutical Ingredients Industry Trends
13.2 Heparin Active Pharmaceutical Ingredients Market Drivers
13.3 Heparin Active Pharmaceutical Ingredients Market Challenges
13.4 Heparin Active Pharmaceutical Ingredients Market Restraints

14 Key Findings in The Global Heparin Active Pharmaceutical Ingredients Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

表と図のリスト

List of Tables
    Table 1. Global Heparin Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Heparin Sodium
    Table 3. Major Manufacturers of Heparin Calcium
    Table 4. Global Heparin Active Pharmaceutical Ingredients Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Heparin Active Pharmaceutical Ingredients Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Heparin Active Pharmaceutical Ingredients Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Heparin Active Pharmaceutical Ingredients Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Region (2019-2024)
    Table 9. Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Region (2025-2030)
    Table 10. Global Heparin Active Pharmaceutical Ingredients Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Heparin Active Pharmaceutical Ingredients Sales by Region (2019-2024) & (K MT)
    Table 12. Global Heparin Active Pharmaceutical Ingredients Sales by Region (2025-2030) & (K MT)
    Table 13. Global Heparin Active Pharmaceutical Ingredients Sales Market Share by Region (2019-2024)
    Table 14. Global Heparin Active Pharmaceutical Ingredients Sales Market Share by Region (2025-2030)
    Table 15. Global Heparin Active Pharmaceutical Ingredients Sales by Manufacturers (2019-2024) & (K MT)
    Table 16. Global Heparin Active Pharmaceutical Ingredients Sales Share by Manufacturers (2019-2024)
    Table 17. Global Heparin Active Pharmaceutical Ingredients Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Heparin Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Heparin Active Pharmaceutical Ingredients, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Heparin Active Pharmaceutical Ingredients Price by Manufacturers 2019-2024 (USD/MT)
    Table 21. Global Heparin Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Heparin Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Active Pharmaceutical Ingredients as of 2023)
    Table 23. Global Key Manufacturers of Heparin Active Pharmaceutical Ingredients, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Heparin Active Pharmaceutical Ingredients, Product Offered and Application
    Table 25. Global Key Manufacturers of Heparin Active Pharmaceutical Ingredients, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2024) & (K MT)
    Table 28. Global Heparin Active Pharmaceutical Ingredients Sales by Type (2025-2030) & (K MT)
    Table 29. Global Heparin Active Pharmaceutical Ingredients Sales Share by Type (2019-2024)
    Table 30. Global Heparin Active Pharmaceutical Ingredients Sales Share by Type (2025-2030)
    Table 31. Global Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Heparin Active Pharmaceutical Ingredients Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Heparin Active Pharmaceutical Ingredients Revenue Share by Type (2019-2024)
    Table 34. Global Heparin Active Pharmaceutical Ingredients Revenue Share by Type (2025-2030)
    Table 35. Heparin Active Pharmaceutical Ingredients Price by Type (2019-2024) & (USD/MT)
    Table 36. Global Heparin Active Pharmaceutical Ingredients Price Forecast by Type (2025-2030) & (USD/MT)
    Table 37. Global Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2024) & (K MT)
    Table 38. Global Heparin Active Pharmaceutical Ingredients Sales by Application (2025-2030) & (K MT)
    Table 39. Global Heparin Active Pharmaceutical Ingredients Sales Share by Application (2019-2024)
    Table 40. Global Heparin Active Pharmaceutical Ingredients Sales Share by Application (2025-2030)
    Table 41. Global Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Heparin Active Pharmaceutical Ingredients Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Heparin Active Pharmaceutical Ingredients Revenue Share by Application (2019-2024)
    Table 44. Global Heparin Active Pharmaceutical Ingredients Revenue Share by Application (2025-2030)
    Table 45. Heparin Active Pharmaceutical Ingredients Price by Application (2019-2024) & (USD/MT)
    Table 46. Global Heparin Active Pharmaceutical Ingredients Price Forecast by Application (2025-2030) & (USD/MT)
    Table 47. US & Canada Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2024) & (K MT)
    Table 48. US & Canada Heparin Active Pharmaceutical Ingredients Sales by Type (2025-2030) & (K MT)
    Table 49. US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2024) & (K MT)
    Table 52. US & Canada Heparin Active Pharmaceutical Ingredients Sales by Application (2025-2030) & (K MT)
    Table 53. US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Heparin Active Pharmaceutical Ingredients Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Heparin Active Pharmaceutical Ingredients Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Heparin Active Pharmaceutical Ingredients Sales by Country (2019-2024) & (K MT)
    Table 59. US & Canada Heparin Active Pharmaceutical Ingredients Sales by Country (2025-2030) & (K MT)
    Table 60. Europe Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2024) & (K MT)
    Table 61. Europe Heparin Active Pharmaceutical Ingredients Sales by Type (2025-2030) & (K MT)
    Table 62. Europe Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Heparin Active Pharmaceutical Ingredients Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2024) & (K MT)
    Table 65. Europe Heparin Active Pharmaceutical Ingredients Sales by Application (2025-2030) & (K MT)
    Table 66. Europe Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Heparin Active Pharmaceutical Ingredients Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Heparin Active Pharmaceutical Ingredients Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Heparin Active Pharmaceutical Ingredients Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Heparin Active Pharmaceutical Ingredients Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Heparin Active Pharmaceutical Ingredients Sales by Country (2019-2024) & (K MT)
    Table 72. Europe Heparin Active Pharmaceutical Ingredients Sales by Country (2025-2030) & (K MT)
    Table 73. China Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2024) & (K MT)
    Table 74. China Heparin Active Pharmaceutical Ingredients Sales by Type (2025-2030) & (K MT)
    Table 75. China Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Heparin Active Pharmaceutical Ingredients Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2024) & (K MT)
    Table 78. China Heparin Active Pharmaceutical Ingredients Sales by Application (2025-2030) & (K MT)
    Table 79. China Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Heparin Active Pharmaceutical Ingredients Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2024) & (K MT)
    Table 82. Asia Heparin Active Pharmaceutical Ingredients Sales by Type (2025-2030) & (K MT)
    Table 83. Asia Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Heparin Active Pharmaceutical Ingredients Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2024) & (K MT)
    Table 86. Asia Heparin Active Pharmaceutical Ingredients Sales by Application (2025-2030) & (K MT)
    Table 87. Asia Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Heparin Active Pharmaceutical Ingredients Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Heparin Active Pharmaceutical Ingredients Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Heparin Active Pharmaceutical Ingredients Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Heparin Active Pharmaceutical Ingredients Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Heparin Active Pharmaceutical Ingredients Sales by Region (2019-2024) & (K MT)
    Table 93. Asia Heparin Active Pharmaceutical Ingredients Sales by Region (2025-2030) & (K MT)
    Table 94. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Type (2019-2024) & (K MT)
    Table 95. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Type (2025-2030) & (K MT)
    Table 96. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Application (2019-2024) & (K MT)
    Table 99. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Application (2025-2030) & (K MT)
    Table 100. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Country (2019-2024) & (K MT)
    Table 106. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales by Country (2025-2030) & (K MT)
    Table 107. Shenzhen Hepalink Pharmaceutical Company Information
    Table 108. Shenzhen Hepalink Pharmaceutical Description and Major Businesses
    Table 109. Shenzhen Hepalink Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. Shenzhen Hepalink Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Shenzhen Hepalink Pharmaceutical Recent Developments
    Table 112. Yantai Dongcheng Pharmaceutical Company Information
    Table 113. Yantai Dongcheng Pharmaceutical Description and Major Businesses
    Table 114. Yantai Dongcheng Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Yantai Dongcheng Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Yantai Dongcheng Pharmaceutical Recent Developments
    Table 117. Nanjing King-friend Biochemical Pharmaceutical Company Information
    Table 118. Nanjing King-friend Biochemical Pharmaceutical Description and Major Businesses
    Table 119. Nanjing King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. Nanjing King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Nanjing King-friend Biochemical Pharmaceutical Recent Developments
    Table 122. Pfizer Company Information
    Table 123. Pfizer Description and Major Businesses
    Table 124. Pfizer Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. Pfizer Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Pfizer Recent Developments
    Table 127. Hebei Changshan Biochemical Pharmaceutical Company Information
    Table 128. Hebei Changshan Biochemical Pharmaceutical Description and Major Businesses
    Table 129. Hebei Changshan Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 130. Hebei Changshan Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Hebei Changshan Biochemical Pharmaceutical Recent Developments
    Table 132. Bioibérica Company Information
    Table 133. Bioibérica Description and Major Businesses
    Table 134. Bioibérica Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 135. Bioibérica Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Bioibérica Recent Developments
    Table 137. Qingdao Jiulong Biopharmaceutical Company Information
    Table 138. Qingdao Jiulong Biopharmaceutical Description and Major Businesses
    Table 139. Qingdao Jiulong Biopharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 140. Qingdao Jiulong Biopharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Qingdao Jiulong Biopharmaceutical Recent Developments
    Table 142. Changzhou Qianhong Biopharma Company Information
    Table 143. Changzhou Qianhong Biopharma Description and Major Businesses
    Table 144. Changzhou Qianhong Biopharma Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 145. Changzhou Qianhong Biopharma Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Changzhou Qianhong Biopharma Recent Developments
    Table 147. Dongying Tiandong Pharmaceutical Company Information
    Table 148. Dongying Tiandong Pharmaceutical Description and Major Businesses
    Table 149. Dongying Tiandong Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 150. Dongying Tiandong Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Dongying Tiandong Pharmaceutical Recent Developments
    Table 152. Opocrin Company Information
    Table 153. Opocrin Description and Major Businesses
    Table 154. Opocrin Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 155. Opocrin Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Opocrin Recent Developments
    Table 157. Hubei Enoray Biopharmaceutical Company Information
    Table 158. Hubei Enoray Biopharmaceutical Description and Major Businesses
    Table 159. Hubei Enoray Biopharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 160. Hubei Enoray Biopharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Hubei Enoray Biopharmaceutical Recent Developments
    Table 162. Yino Pharma Company Information
    Table 163. Yino Pharma Description and Major Businesses
    Table 164. Yino Pharma Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 165. Yino Pharma Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Yino Pharma Recent Developments
    Table 167. Cisen Pharmaceutical Company Information
    Table 168. Cisen Pharmaceutical Description and Major Businesses
    Table 169. Cisen Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 170. Cisen Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Cisen Pharmaceutical Recent Developments
    Table 172. Nanjing Xinbai Pharmaceutical Company Information
    Table 173. Nanjing Xinbai Pharmaceutical Description and Major Businesses
    Table 174. Nanjing Xinbai Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 175. Nanjing Xinbai Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Nanjing Xinbai Pharmaceutical Recent Developments
    Table 177. Sichuan Deebio Pharmaceutical Company Information
    Table 178. Sichuan Deebio Pharmaceutical Description and Major Businesses
    Table 179. Sichuan Deebio Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 180. Sichuan Deebio Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Sichuan Deebio Pharmaceutical Recent Developments
    Table 182. Key Raw Materials Lists
    Table 183. Raw Materials Key Suppliers Lists
    Table 184. Heparin Active Pharmaceutical Ingredients Distributors List
    Table 185. Heparin Active Pharmaceutical Ingredients Customers List
    Table 186. Heparin Active Pharmaceutical Ingredients Market Trends
    Table 187. Heparin Active Pharmaceutical Ingredients Market Drivers
    Table 188. Heparin Active Pharmaceutical Ingredients Market Challenges
    Table 189. Heparin Active Pharmaceutical Ingredients Market Restraints
    Table 190. Research Programs/Design for This Report
    Table 191. Key Data Information from Secondary Sources
    Table 192. Key Data Information from Primary Sources
List of Figures
    Figure 1. Heparin Active Pharmaceutical Ingredients Product Picture
    Figure 2. Global Heparin Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Heparin Active Pharmaceutical Ingredients Market Share by Type in 2023 & 2030
    Figure 4. Heparin Sodium Product Picture
    Figure 5. Heparin Calcium Product Picture
    Figure 6. Global Heparin Active Pharmaceutical Ingredients Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Heparin Active Pharmaceutical Ingredients Market Share by Application in 2023 & 2030
    Figure 8. UFH
    Figure 9. LMWH
    Figure 10. Heparin Active Pharmaceutical Ingredients Report Years Considered
    Figure 11. Global Heparin Active Pharmaceutical Ingredients Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Heparin Active Pharmaceutical Ingredients Revenue 2019-2030 (US$ Million)
    Figure 13. Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Region (2019-2030)
    Figure 15. Global Heparin Active Pharmaceutical Ingredients Sales 2019-2030 ((K MT)
    Figure 16. Global Heparin Active Pharmaceutical Ingredients Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Heparin Active Pharmaceutical Ingredients Sales YoY (2019-2030) & (K MT)
    Figure 18. US & Canada Heparin Active Pharmaceutical Ingredients Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Heparin Active Pharmaceutical Ingredients Sales YoY (2019-2030) & (K MT)
    Figure 20. Europe Heparin Active Pharmaceutical Ingredients Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Heparin Active Pharmaceutical Ingredients Sales YoY (2019-2030) & (K MT)
    Figure 22. China Heparin Active Pharmaceutical Ingredients Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Heparin Active Pharmaceutical Ingredients Sales YoY (2019-2030) & (K MT)
    Figure 24. Asia (excluding China) Heparin Active Pharmaceutical Ingredients Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales YoY (2019-2030) & (K MT)
    Figure 26. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Heparin Active Pharmaceutical Ingredients Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Heparin Active Pharmaceutical Ingredients in the World: Market Share by Heparin Active Pharmaceutical Ingredients Revenue in 2023
    Figure 29. Global Heparin Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Heparin Active Pharmaceutical Ingredients Sales Market Share by Type (2019-2030)
    Figure 31. Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Type (2019-2030)
    Figure 32. Global Heparin Active Pharmaceutical Ingredients Sales Market Share by Application (2019-2030)
    Figure 33. Global Heparin Active Pharmaceutical Ingredients Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Heparin Active Pharmaceutical Ingredients Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Heparin Active Pharmaceutical Ingredients Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Heparin Active Pharmaceutical Ingredients Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Heparin Active Pharmaceutical Ingredients Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Heparin Active Pharmaceutical Ingredients Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Heparin Active Pharmaceutical Ingredients Sales Share by Country (2019-2030)
    Figure 40. U.S. Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Heparin Active Pharmaceutical Ingredients Sales Market Share by Type (2019-2030)
    Figure 43. Europe Heparin Active Pharmaceutical Ingredients Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Heparin Active Pharmaceutical Ingredients Sales Market Share by Application (2019-2030)
    Figure 45. Europe Heparin Active Pharmaceutical Ingredients Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Heparin Active Pharmaceutical Ingredients Revenue Share by Country (2019-2030)
    Figure 47. Europe Heparin Active Pharmaceutical Ingredients Sales Share by Country (2019-2030)
    Figure 48. Germany Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 49. France Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 53. China Heparin Active Pharmaceutical Ingredients Sales Market Share by Type (2019-2030)
    Figure 54. China Heparin Active Pharmaceutical Ingredients Revenue Market Share by Type (2019-2030)
    Figure 55. China Heparin Active Pharmaceutical Ingredients Sales Market Share by Application (2019-2030)
    Figure 56. China Heparin Active Pharmaceutical Ingredients Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Heparin Active Pharmaceutical Ingredients Sales Market Share by Type (2019-2030)
    Figure 58. Asia Heparin Active Pharmaceutical Ingredients Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Heparin Active Pharmaceutical Ingredients Sales Market Share by Application (2019-2030)
    Figure 60. Asia Heparin Active Pharmaceutical Ingredients Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Heparin Active Pharmaceutical Ingredients Revenue Share by Region (2019-2030)
    Figure 62. Asia Heparin Active Pharmaceutical Ingredients Sales Share by Region (2019-2030)
    Figure 63. Japan Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 67. India Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Heparin Active Pharmaceutical Ingredients Sales Share by Country (2019-2030)
    Figure 74. Brazil Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Heparin Active Pharmaceutical Ingredients Revenue (2019-2030) & (US$ Million)
    Figure 79. Heparin Active Pharmaceutical Ingredients Value Chain
    Figure 80. Heparin Active Pharmaceutical Ingredients Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed

以下、関連資料のご紹介